inhibitors of the cytosolic phospholypase a2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases . the inhibitors of the present invention have the general formula where x , z , x 1 , r 1 , r 2 , r a and r b are as defined in the specification .